Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies

Abstract Background One of the major challenges in diagnosing dementia with Lewy bodies (DLB) is the common co-morbid presence of amyloid pathology. To understand the putative role of altered amyloid-β (Aβ) metabolism in dementia with DLB, we analyzed levels of different cerebrospinal fluid (CSF) Aβ...

Full description

Bibliographic Details
Main Authors: Inger van Steenoven, Wiesje M. van der Flier, Philip Scheltens, Charlotte E. Teunissen, Afina W. Lemstra
Format: Article
Language:English
Published: BMC 2019-10-01
Series:Alzheimer’s Research & Therapy
Subjects:
Cerebrospinal fluid
Dementia with Lewy bodies
Amyloid-β peptides
Co-morbid Alzheimer’s disease pathology
Online Access:http://link.springer.com/article/10.1186/s13195-019-0537-5

Internet

http://link.springer.com/article/10.1186/s13195-019-0537-5

Similar Items